The DOI matches its Crossref record.
Percutaneous nephrostomy versus retrograde ureteral stenting for acute upper obstructive uropathy: a systematic review and meta-analysis
Published version of a preprint
Abstract
Acute obstructive uropathy is associated with significant morbidity among patients with any condition that leads to urinary tract obstruction. Immediate urinary diversion is necessary to prevent further damage to the kidneys. In many centres, the two main treatment options include percutaneous nephrostomy (PCN) and retrograde ureteral stenting (RUS). The purpose of this study if to compare the efficacy and safety of PCN and RUS for the treatment of acute obstructive uropathy. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, CINAHL, EMBASE, the World Health Organisation International Clinical Trials Registry Platform and ClinicalTrials.gov. We also searched the reference lists of included studies to identify any additional trials. We included randomised controlled trials and controlled clinical trials comparing the outcomes of clinical improvement (septic parameters), hospitalisation duration, quality of life, urinary-related symptoms, failure rates, post-procedural pain [measured using a visual analogue scale (VAS)] and analgesics use. We conducted statistical analyses using random effects models and expressed the results as risk ratio (RR) and risk difference (RD) for dichotomous outcomes and mean difference (MD) for continuous outcomes, with 95% confidence intervals (CIs). Seven trials were identified that included 667 patients. Meta-analysis of the data revealed no difference in the two methods in improvement of septic parameters, quality of life, failure rates, post-procedural pain (VAS), or analgesics use. Patients receiving PCN had lower rates of haematuria and dysuria post-operatively and longer hospitalisation duration than those receiving RUS. PCN and RUS are effective for the decompression of an obstructed urinary system, with no significant difference in most outcomes. However, PCN is preferable to RUS because of its reduced impact on the patient’s post-operative quality of life due to haematuria and dysuria, although it is associated with slightly longer hospitalisation duration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“similarly found no significant difference in improvement of septic parameters, failure rates, or EQ-5D quality-of-life domains, but noted that PCN was associated with less post-procedural hematuria and dysuria—on which basis its authors favored PCN—at the cost of a longer hospital stay (mean difference 1.82 days, 95% CI 0.79–2.85) [62]”
From Pyonephrosis—An Updated Morphological Glimpse into the Contemporary Management of an Immemorial Pathology: A Narrative Review (2026) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 32
- Tseng, T. Y. & Stoller, M. L. Obstructive uropathy. Clin. Geriatr. Med. 25(3), 437–443 (2009). · DOI
- Klahr, S. Pathophysiology of obstructive nephropathy. Kidney Int. 23(2), 414–426 (1983). · doi:10.1038/ki.1983.36
- Vaughan, E. D. Jr., Marion, D., Poppas, D. P. & Felsen, D. Pathophysiology of unilateral ureteral obstruction: studies from Charlottesville to New York. J. Urol. 172(6 Pt 2), 2563–2569 (2004). · doi:10.1097/01.ju.0000144286.53562.95
- Lynch, M. F., Anson, K. M. & Patel, U. Current opinion amongst radiologists and urologists in the UK on percutaneous nephrostomy and ureteric stent insertion for acute renal unobstruction: Results of a postal survey. BJU Int. 98(6), 1143–1144 (2006). · doi:10.1111/j.1464-410x.2006.06513.x
- Bansal, T. et al. Obstructive nephropathy and chronic kidney disease secondary to uterine leiomyomas. Arch. Gynecol. Obstet. 279(6), 785–788 (2009). · doi:10.1007/s00404-008-0769-2
- Pearle, M. S. et al. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. J. Urol. 160(4), 1260–1264 (1998). · DOI · Paper page
- Joshi, H. B., Adams, S., Obadeyi, O. O. & Rao, P. N. Nephrostomy tube or “JJ” ureteric stent in ureteric obstruction: Assessment of patient perspectives using quality-of-life survey and utility analysis. Eur. Urol. 39(6), 695–701 (2001). · doi:10.1159/000052529
- Mokhmalji, H. et al. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: A prospective, randomized clinical trial. J. Urol. 165(4), 1088–1092 (2001). · DOI · Paper page
- Ahmad, I. et al. Comparison between double J (DJ) ureteral stenting and percutaneous nephrostomy (PCN) in obstructive uropathy. Pak. J. Med. Sci. 29(3), 725–729 (2013). · doi:10.12669/pjms.293.3563
- Monsky, W. L. et al. Quality-of-life assessment after palliative interventions to manage malignant ureteral obstruction. Cardiovasc. Intervent. Radiol. 36(5), 1355–1363 (2013). · DOI
- Wang, C. J., Hsu, C. S., Chen, H. W., Chang, C. H. & Tsai, P. C. Percutaneous nephrostomy versus ureteroscopic management of sepsis associated with ureteral stone impaction: A randomized controlled trial. Urolithiasis. 44(5), 415–419 (2016). · DOI · Paper page
- de Sousa Morais, N., et al. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study. Urolithiasis. (2018). · doi:10.1007/s00240-018-1078-2
- Shoshany, O. et al. Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction—Clinical outcome and quality of life: A bi-center prospective study. BMC Urol. 19(1), 79 (2019). · DOI · Paper page
- De Sousa Morais, N. et al. Which is the better urinary diversion regarding tolerability and quality of life-percutaneous nephrostomy vs ureteral stent: A prospective study. J. Endourol. 32, A70 (2018).
- Aravantinos, E. et al. Percutaneous nephrostomy in patients with tumors of advanced stage: Treatment dilemmas and impact on clinical course and quality of life. J. Endourol. 21(11), 1297–1302 (2007). · doi:10.1089/end.2006.0104
- Emmert, C., Rassler, J. & Kohler, U. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer. Arch. Gynecol. Obstet. 259(3), 147–151 (1997). · doi:10.1007/bf02505324
- Flukes, S. et al. Retrograde ureteric stent insertion in the management of infected obstructed kidneys. BJU Int. 115(Suppl 5), 31–34 (2015). · doi:10.1111/bju.12918
- Gasparini, M., Carroll, P. & Stoller, M. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction. Urology 38(5), 408–412 (1991). · doi:10.1016/0090-4295(91)80227-x
- Ku, J. H., Lee, S. W., Jeon, H. G., Kim, H. H. & Oh, S. J. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: Are there differences?. Urology 64(5), 895–899 (2004). · doi:10.1016/j.urology.2004.06.029
- Netsch, C., Becker, B. & Gross, A. J. Management of ureteral obstruction: Value of percutaneous nephrostomy and ureteral stents. Urologe 55(11), 1497–1510 (2016). · doi:10.1007/s00120-016-0253-8
- Pappas, P. et al. Role of percutaneous urinary diversion in malignant and benign obstructive uropathy. J. Endourol. 14(5), 401–405 (2000). · doi:10.1089/end.2000.14.401
- Gorelov, S., Zedan, F. & Startsev, V. The choice of urinary drainage in patients with ureteral calculi of solitary kidneys. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.76(2), 56–8 (2004).
- Hepperlen, T. W., Mardis, H. K. & Kammandel, H. The pigtail ureteral stent in the cancer patient. J. Urol. 121(1), 17–18 (1979). · doi:10.1016/s0022-5347(17)56643-4
- Uppot, R. N. & Uppot, R. N. Emergent nephrostomy tube placement for acute urinary obstruction. Tech. Vasc. Interv. Radiol. 12(2), 154–161 (2009). · doi:10.1053/j.tvir.2009.08.010
- Wilson, J. R., Urwin, G. H. & Stower, M. J. The role of percutaneous nephrostomy in malignant ureteric obstruction. Ann. R. Coll. Surg. Engl. 87(1), 21–24 (2005). · doi:10.1308/1478708051432
- Zhao, P. T., Hoenig, D. M., Smith, A. D. & Okeke, Z. A randomized controlled comparison of nephrostomy drainage vs ureteral stent following percutaneous nephrolithotomy using the Wisconsin stone QOL. J. Endourol. 30(12), 1275–1284 (2016). · doi:10.1089/end.2016.0235
- Pasiechnikov, S., Buchok, O., Sheremeta, R. & Banyra, O. Empirical treatment in patients with acute obstructive pyelonephritis. Infect. Disord. Drug Targets 15(3), 163–170 (2015). · doi:10.2174/1871526515666150831144801
- Mokhmalji, H. et al. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: A prospective, randomized clinical trial. J. Urol. 165(4), 1088–1092 (2001). · DOI · Paper page
- Pearle, M. S. et al. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. J. Urol. 160(4), 1260–1264 (1998). · DOI · Paper page
- Hsu, L. et al. Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction. World J. Nephrol. 5(2), 172–181 (2016). · doi:10.5527/wjn.v5.i2.172
- Higgins, T., et al. Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). Cochrane. (2019). · DOI · Paper page
- Guyatt, G., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. 2011(1878–5921 (Electronic)). · DOI · Paper page
Cited by
Latcu, S., Novacescu, D., Baloi, A., Zara, F., Dumitru, C.-S., Caprariu, R., Cut, T. G., Marinescu, A., Lazureanu, V. E., Bratosin, F., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16203334
Metadata
- Authors
- Zul Khairul Azwadi, I., Norhayati, M. N., & Abdullah, M. S.
- Venue
- Scientific Reports
- Published
- 2021-03-23
- Volume
- 11
- Issue
- 1
- ISSN
- 2045-2322
- Cited by
- 41
- References
- 0
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Percutaneous nephrostomy versus retrograde ureteral stenting for acute upper obstructive uropathy: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1038/s41598-021-86136-y
- The paper
- Zul Khairul Azwadi, I., Norhayati, M. N., & Abdullah, M. S. (2021). Percutaneous nephrostomy versus retrograde ureteral stenting for acute upper obstructive uropathy: a systematic review and meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-021-86136-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.